Latest Safety News

BlueScope has appointed Tania Archibald as its new Managing Director and CEO, succeeding Mark Vassella who retires after eight years. Archibald’s extensive internal experience positions her to lead the company’s next strategic phase.

Woodside Energy Group unveiled an ambitious growth strategy at its 2025 Capital Markets Day, targeting a net operating cash flow of around US$9 billion by the early 2030s, driven by key LNG and ammonia projects.

Resolute Mining confirms steady operations at its Syama gold mine in Mali despite ongoing supply chain hurdles and unpredictable local conditions.

Brightstar Resources has enhanced its leadership team with seasoned mining executives and is advancing its Sandstone project, targeting a resource upgrade in early 2026 as it pursues a +200,000-ounce annual gold production goal.

Imricor Medical Systems and Amsterdam UMC have completed the first-ever ischemic ventricular tachycardia ablation fully guided by real-time MRI, marking a major advance in cardiac electrophysiology.

G8 Education has revised down its full-year earnings forecast due to ongoing occupancy challenges and increased regulatory investments, signaling continued sector pressures.

Nido Education updates its 2025 financial outlook and growth plans, highlighting sector challenges and upcoming government childcare subsidy reforms that could reshape demand.

Livium Ltd has been granted a patent protecting its innovative wet shredding process for lithium-ion battery recycling, enhancing safety and operational efficiency. This milestone solidifies its position in the evolving clean energy recycling sector.

Anteris Technologies has secured FDA approval to commence its pivotal PARADIGM clinical trial, testing its innovative DurAVR Transcatheter Heart Valve against established devices in patients with severe aortic stenosis.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Vertex Minerals has commenced underground ore production at its Reward Gold Mine in New South Wales, processing high-grade ore through a gravity-only plant with strong recoveries. The company also advanced its A$11 million capital raising, positioning itself for steady growth into 2026.